Can Taking Mounjaro Cause Hair Loss? What You Need To Know

Last reviewed: July 11, 2026

Last updated: July 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, a dual GLP-1 and GIP receptor agonist, has become a popular choice for weight management, yet some patients report hair loss during treatment. This side effect is not caused by the medication itself but rather by rapid weight loss triggering telogen effluvium, a temporary condition where hair follicles shift into a resting phase. PlexusDx provides personalized tirzepatide therapy with clinical support to help you navigate potential side effects.

Why Tirzepatide Might Trigger Hair Shedding

Hair loss during GLP-1 or tirzepatide therapy typically stems from the speed of weight reduction rather than the medication's chemical properties. When the body loses weight rapidly, it perceives nutritional stress, causing hair roots to enter a dormant phase called telogen effluvium. This process usually begins 2 to 3 months after significant weight loss begins and can last several months as new hairs push out the resting ones.

Tirzepatide's powerful appetite-suppressing effects allow patients to lose weight faster than through diet alone, which can accelerate telogen effluvium onset. The medication reduces hunger signals and increases satiety, helping people achieve substantial calorie deficits quickly. While this effectiveness is beneficial for weight management, the rapid metabolic shift can deplete micronutrients critical for hair health, including iron, zinc, and B vitamins.

Hair Loss Versus Hair Shedding: Understanding the Difference

Not all hair that falls out during tirzepatide treatment represents permanent hair loss. Telogen effluvium is reversible shedding that typically resolves within 6 to 12 months after weight stabilizes and nutritional status improves. The hair follicles themselves remain healthy and capable of producing new growth once the stress stimulus ends.

Permanent hair loss, by contrast, involves damage to the hair follicle itself and is rare with tirzepatide therapy. If you experience patchy baldness, scalp inflammation, or hair loss beyond the first year of treatment, consult a dermatologist to rule out other underlying conditions such as thyroid dysfunction or autoimmune alopecia, which may require separate investigation and care.

How to Minimize Hair Shedding While Taking Tirzepatide

Maintaining adequate protein intake is essential to support hair growth during rapid weight loss on tirzepatide. Aim for 0.8 to 1.0 grams of protein per pound of body weight daily, prioritizing lean meats, fish, eggs, and plant-based sources. Protein provides amino acids such as methionine and cysteine that form the structural basis of hair, and deficiency accelerates telogen shedding.

Micronutrient supplementation can help protect hair health during tirzepatide therapy. Consider adding a multivitamin containing iron, zinc, biotin, and vitamin D, or discuss targeted supplementation with your PlexusDx clinical team based on your individual needs. Additionally, manage stress through sleep, exercise, and relaxation techniques, as chronic stress compounds hair shedding by prolonging the telogen phase.

Personalized Tirzepatide Treatment at PlexusDx

PlexusDx offers compounded tirzepatide injections starting at $289/mo (or $249/mo on the 6-month plan) from licensed 503A compounding pharmacies, with no flat per-compound pricing tiers—your dose may need to go up, but your price won't. The flat-fee model ensures transparent, predictable costs regardless of dosage adjustments, and treatment is available across all 50 states without insurance requirements or membership fees.

To optimize your tirzepatide experience and identify genetic predispositions to side effects, PlexusDx offers the Precision Peptide Genetic Test as a $99 add-on after your first month of treatment. This test maps 14 metabolic pathways and 49 peptide-related genes, including variants affecting appetite regulation (GLP1R rs6923761) and metabolism (FTO rs9939609), helping your clinician personalize your treatment plan to minimize adverse effects while maximizing weight loss results. HSA and FSA accounts are accepted for all services.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How long does hair shedding last when taking tirzepatide?

Telogen effluvium typically begins 2 to 3 months after rapid weight loss starts and resolves within 6 to 12 months as weight stabilizes. Most patients see improvement once they reach their target weight and maintain adequate nutrition. If shedding persists beyond 12 months, consult your healthcare provider to explore other potential causes.

Is the hair loss from tirzepatide permanent?

No, hair loss from tirzepatide is almost always temporary and reversible. Telogen effluvium does not damage hair follicles permanently; it simply pauses growth temporarily. Once weight stabilizes and nutrient levels normalize, hair re-enters the growth phase and shedding typically stops.

Can I prevent hair loss while taking tirzepatide?

You can reduce shedding by maintaining high protein intake (0.8–1.0 g per pound of body weight), taking a quality multivitamin with iron and zinc, managing stress, and getting adequate sleep. Slower, steadier weight loss also decreases telogen effluvium risk. Discuss preventive strategies with your PlexusDx clinician before starting treatment.

Does PlexusDx help manage tirzepatide side effects?

Yes, PlexusDx provides clinical support and education on side effect management with every compounded tirzepatide prescription. Tirzepatide injections start at $289/mo (or $249/mo on the 6-month plan), and you can add the Precision Peptide Genetic Test ($99) to identify your personal risk factors for hair shedding and other metabolic responses based on your genetic profile.

How does the Precision Peptide Genetic Test help with hair loss risk?

PlexusDx's Precision Peptide Genetic Test analyzes peptide-pathway variants including FTO rs9939609 and GLP1R rs6923761 that influence weight loss speed and metabolic stress response. Knowing your genetic predispositions allows your clinician to adjust your tirzepatide dosing strategy and nutrition plan to reduce telogen effluvium risk before it develops.

Related Reading

• Genetic Testing 101 What You Need To Know Before Getting Tested
• Mounjaro For Weight Loss 2
• Glp 1 Hair Loss Plexusdx
• Weight Loss Mounjaro

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.